From: Breast cancer care in northern Ethiopia – cross-sectional analysis
Characteristics | Number | Proportion |
---|---|---|
Total Population | 82 | 100% |
Duration of symptoms in months | ||
≤ 4 | 8 | 10% |
5–8 | 20 | 24% |
9–16 | 28 | 34% |
17–24 | 15 | 18% |
≥ 25 | 11 | 13% |
Menopausal Status (Women Only) | ||
Pre-menopausal | 38 | 57% |
Post-menopausal | 29 | 43% |
Main presenting Symptom | ||
Breast pain | 1 | 1% |
Breast Swelling | 65 | 79% |
Pain outside breast | 1 | 1% |
Ulceration | 15 | 18% |
Lateralization | ||
Right Breast | 48 | 59% |
Left Breast | 32 | 39% |
Bilateral | 2 | 2% |
Type of Surgery performed | ||
Surgery was not performed | 26 | 32% |
Modified Radical Mastectomy | 51 | 62% |
Simple Mastectomy | 2 | 2% |
Palliative Mastectomy | 3 | 4% |
Histology | ||
Ductal Carcinoma | 61 | 74% |
Breast Cancer NST | 17 | 21% |
DCIS | 1 | 1% |
Lobular Carcinoma | 1 | 1% |
Mucinous Carcinoma | 1 | 1% |
Papillary Carcinoma | 1 | 1% |
Grade of Differentiation | ||
G-1 | 14 | 17% |
G-2 | 30 | 37% |
G-3 | 26 | 32% |
Not reported | 12 | 15% |
First-line chemotherapy Given | ||
AC | 50 | 61% |
FAC | 14 | 17% |
AC + taxol | 13 | 16% |
Chemotherapy not started | 3 | 4% |
CAF | 1 | 1% |
CMF | 1 | 1% |
Hormonal Therapy | ||
Anastrazole | 6 | 7% |
No hormonal therapy | 22 | 27% |
On Chemotherapy | 36 | 44% |
Tamoxifen | 18 | 22% |